These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29288619)

  • 1. Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China.
    Zhong Z; Hou J; Li B; Zhang Q; Liu S; Li C; Liu Z; Yang M; Zhong W; Zhao P
    Med Sci Monit; 2017 Dec; 23():6186-6192. PubMed ID: 29288619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.
    Zhong Z; Hou J; Zhang Q; Li B; Li C; Liu Z; Yang M; Zhong W; He X; Wu H; Zhong M; Zhao P
    Eur J Clin Pharmacol; 2018 Apr; 74(4):423-431. PubMed ID: 29243114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects.
    Song BL; Wan M; Tang D; Sun C; Zhu YB; Linda N; Fan HW; Zou JJ
    Clin Ther; 2018 Jul; 40(7):1170-1178. PubMed ID: 30017169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
    Subraja K; Dkhar SA; Priyadharsini R; Ravindra BK; Shewade DG; Satheesh S; Sridhar MG; Narayan SK; Adithan C
    Eur J Clin Pharmacol; 2013 Mar; 69(3):415-22. PubMed ID: 22955794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
    Hokimoto S; Chitose T; Mizobe M; Akasaka T; Arima Y; Kaikita K; Iwashita S; Morita K; Miyazaki H; Oniki K; Matsui K; Nakagawa K; Ogawa H
    Eur J Clin Pharmacol; 2014 Jun; 70(6):667-73. PubMed ID: 24763934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study.
    Cai N; Li C; Gu X; Zeng W; Zhong J; Liu J; Zeng G; Zhu J; Hong H
    BMC Cardiovasc Disord; 2023 Apr; 23(1):185. PubMed ID: 37024851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia.
    Lee J; Cheng N; Tai H; Jimmy Juang J; Wu C; Lin L; Hwang J; Lin J; Chiang F; Tsai C
    Eur J Vasc Endovasc Surg; 2019 Sep; 58(3):373-382. PubMed ID: 31395432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphisms of the Mitochondrial Aldehyde Dehydrogenase ALDH2 Gene in a Large Ethnic Hakka Population in Southern China.
    Zhong Z; Hou J; Li B; Zhang Q; Li C; Liu Z; Yang M; Zhong W; Zhao P
    Med Sci Monit; 2018 Apr; 24():2038-2044. PubMed ID: 29623947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang.
    Li Y; Yang H; Zou X; Xiong L; Li Z; Luo J; Zhao B; Liu W; Du X
    Med Sci Monit; 2014 Nov; 20():2213-8. PubMed ID: 25381554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CYP2C19 loss-of-function variants on the metabolism of clopidogrel in patients from north-western China.
    Lin R; Zhang L; Zhang P; Zhou L; Liu T; Li Y; Zhang W; Wang W; Zhang J
    J Clin Pharm Ther; 2015 Jun; 40(3):308-14. PubMed ID: 25810245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome
    Ahmed S; Gul S; Akhlaq M; Hussain A; Tariq Khan S; Rehman H; Hanif Bangash M; Al Mughairbi F; Hamid Hamdard M
    Bioengineered; 2021 Dec; 12(1):4442-4451. PubMed ID: 34308762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CYP2C19 gene polymorphisms and lipid metabolism in Chinese patients with ischemic stroke.
    Bai Y; Huang R; Wan L; Zhao R
    J Int Med Res; 2020 Jul; 48(7):300060520934657. PubMed ID: 32644829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.
    Wang JH; Li PQ; Fu QY; Li QX; Cai WW
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):421-4. PubMed ID: 17439410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.
    Liu T; Yin T; Li Y; Song LQ; Yu J; Si R; Zhang YM; He Y; Guo WY; Wang HC
    Coron Artery Dis; 2014 Aug; 25(5):412-20. PubMed ID: 24608794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C19, PON1, and ABCB1 gene polymorphisms in Han and Uygur populations with coronary artery disease in Northwestern Xinjiang, China, From 2014 Through 2019.
    Wang T; Zhao T; Bao S; Jia L; Feng J; Yu A; Sun L; Guo X; Li H; Yu L
    Medicine (Baltimore); 2020 Jul; 99(29):e20582. PubMed ID: 32702814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms and phenotypic analysis of drug-metabolizing enzyme CYP2C19 in a Li Chinese population.
    Ding Y; Xu D; Zhang X; Yang H; Geng T; He P; Yao J; Yi S; Xu H; Wu D; Wang X; Jin T
    Int J Clin Exp Pathol; 2015; 8(10):13201-8. PubMed ID: 26722519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
    Fang L; Zhao Y; Wang N; Yang Z; Huang H; Lin M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):871-6. PubMed ID: 26663068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population.
    Tayeb HT; Bakheet DH; Zaza K; Wakil SM; Dzimiri N
    J Pharm Pharmacol; 2015 Jul; 67(7):972-9. PubMed ID: 25684066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.
    Saeed LH; Mayet AY
    Int J Med Sci; 2013; 10(11):1497-502. PubMed ID: 24046523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.